An Antimicrobial Blue Light Prototype Device Controls Infected Wounds in a Preclinical Porcine Model.

In all postinfection groups, ABL-treated wounds demonstrated highly significant log CFU/g reductions in MRSA compared to dark controls, at both times postirradiation (24 hours and 30 minutes).

also in 132,142 other papers